Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine , Cincinnati, OH, USA.
Department of Information Services, The MetroHealth System , Cleveland, OH, USA.
Am J Drug Alcohol Abuse. 2020 Jul 3;46(4):454-461. doi: 10.1080/00952990.2019.1676433. Epub 2019 Nov 19.
Understanding the potential impact of cannabis use on cardiovascular health is increasingly important as cannabis use rises in the U.S. Objectives: This study evaluated the associations between regular cannabis use, with and without tobacco co-use, and cardiovascular outcomes.
Analysis of a limited dataset obtained through IBM Watson Health Explorys, a platform integrating electronic health record data. Matched controls using Mahalanobis distance within propensity score calipers were defined for: 1) cannabis-using patients (n = 8,944; 43% female); and subgroups of cannabis-using patients: 2) with an encounter diagnosis for tobacco use disorder (TUD; n = 4,682); and 3) without a TUD diagnosis (non-TUD; n = 4,262). Patients had ≥1 blood pressure measurement and blood chemistry lab result in the MetroHealth System (Cleveland, Ohio). Cannabis-using patients had an encounter diagnosis of cannabis abuse/dependence and/or ≥2 cannabis-positive urine drug screens. Control patients, with no cannabis-use-documentation, were matched to the cannabis-using patients on demographics, residential zip code median income, body mass index, and, for the total sample, TUD-status. Outcomes were encounter diagnosis (yes/no) of cerebrovascular accident (CVA), heart arrhythmia, myocardial infarction, subarachnoid hemorrhage (SAH), and all-cause mortality.
TUD-patients had the greatest prevalence of cardiovascular disease, regardless of cannabis-use indication. In the total sample and non-TUD subgroup, regular cannabis use was significantly associated with greater risk for CVA, arrhythmia, SAH, and mortality. In the TUD subgroup, regular cannabis use was significantly associated with greater risk for arrhythmia and SAH.
Cannabis use is associated with significantly greater risk of adverse cardiovascular diagnoses and overall death, particularly in non-tobacco users.
随着美国大麻使用量的增加,了解大麻使用对心血管健康的潜在影响变得越来越重要。目的:本研究评估了常规大麻使用(包括与烟草共同使用和不与烟草共同使用)与心血管结局之间的关联。
通过 IBM Watson Health Explorys(一个整合电子健康记录数据的平台)分析了一个有限的数据集。使用倾向评分卡尺内的马哈拉诺比斯距离为以下患者定义了匹配的对照:1)大麻使用者(n=8944;43%为女性);以及大麻使用者的亚组:2)有烟草使用障碍(TUD)就诊诊断的患者(n=4682);和 3)没有 TUD 诊断的患者(非 TUD;n=4262)。患者在克利夫兰市的 MetroHealth 系统中至少有 1 次血压测量和血液化学实验室结果。大麻使用者有大麻滥用/依赖的就诊诊断和/或≥2 次大麻阳性尿液药物筛查。对照患者没有大麻使用记录,根据人口统计学特征、居住邮政编码中位数收入、体重指数以及总样本中的 TUD 状态与大麻使用者进行匹配。结局为脑血管意外(CVA)、心律失常、心肌梗死、蛛网膜下腔出血(SAH)和全因死亡率的就诊诊断(是/否)。
无论大麻使用的指征如何,TUD 患者的心血管疾病患病率最高。在总样本和非 TUD 亚组中,常规大麻使用与 CVA、心律失常、SAH 和死亡率增加显著相关。在 TUD 亚组中,常规大麻使用与心律失常和 SAH 的风险增加显著相关。
大麻使用与不良心血管诊断和总体死亡的风险显著增加相关,尤其是在非烟草使用者中。